Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cheng

Showing results (611-620 of 644) with videos related to

Pageof 65
Sort By:
British Journal of Cancer|October 8, 2014
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumoursI Brana, R Berger, T Golan, et al.
Nature Materials|January 31, 2024
Self-assembled soft alloy with Frank-Kasper phases beyond metalsXian-You Liu, Xiao-Yun Yan, Yuchu Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2016
Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated SubjectsYunda Huang, Guido Ferrari, Galit Alter, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|June 19, 2021
[Three dimensional nephrometry system for partial nephrectomy: Our initial exploration]X F Li, Y J Peng, X T Yu, et al.
Journal of Dental Research|July 9, 2019
HPV Status Improves Classification of Head and Neck Gray Zone CancersJ Ren, W Xu, J Su, et al.
Annals of Surgical Oncology|July 11, 2024
ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2BOzgur Can Eren, Pelin Bagci, Serdar Balci, et al.
Annals of Surgical Oncology|July 2, 2024
Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management ProtocolsOzgur Can Eren, Pelin Bagci, Serdar Balci, et al.
The American Journal of Surgical Pathology|November 15, 2019
Non-neoplastic Polyps of the Gallbladder: A Clinicopathologic Analysis of 447 CasesOrhun C Taskin, Enrique Bellolio, Nevra Dursun, et al.
Clinical Colorectal Cancer|September 2, 2006
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancerSteven J Cohen, R Katherine Alpaugh, Steve Gross, et al.
Archives of Pathology & Laboratory Medicine|May 3, 2023
Adenomyomas of the Gallbladder: An Analysis of Frequency, Clinicopathologic Associations, and Relationship to Carcinoma of a Malformative LesionNevra Dursun, Bahar Memis, Burcin Pehlivanoglu, et al.
Pageof 65

Showing results (611-620 of 644) with videos related to

Sort By:
Pageof 65
British Journal of Cancer|October 8, 2014
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumoursI Brana, R Berger, T Golan, et al.
Nature Materials|January 31, 2024
Self-assembled soft alloy with Frank-Kasper phases beyond metalsXian-You Liu, Xiao-Yun Yan, Yuchu Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2016
Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated SubjectsYunda Huang, Guido Ferrari, Galit Alter, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|June 19, 2021
[Three dimensional nephrometry system for partial nephrectomy: Our initial exploration]X F Li, Y J Peng, X T Yu, et al.
Journal of Dental Research|July 9, 2019
HPV Status Improves Classification of Head and Neck Gray Zone CancersJ Ren, W Xu, J Su, et al.
Annals of Surgical Oncology|July 11, 2024
ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2BOzgur Can Eren, Pelin Bagci, Serdar Balci, et al.
Annals of Surgical Oncology|July 2, 2024
Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management ProtocolsOzgur Can Eren, Pelin Bagci, Serdar Balci, et al.
The American Journal of Surgical Pathology|November 15, 2019
Non-neoplastic Polyps of the Gallbladder: A Clinicopathologic Analysis of 447 CasesOrhun C Taskin, Enrique Bellolio, Nevra Dursun, et al.
Clinical Colorectal Cancer|September 2, 2006
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancerSteven J Cohen, R Katherine Alpaugh, Steve Gross, et al.
Archives of Pathology & Laboratory Medicine|May 3, 2023
Adenomyomas of the Gallbladder: An Analysis of Frequency, Clinicopathologic Associations, and Relationship to Carcinoma of a Malformative LesionNevra Dursun, Bahar Memis, Burcin Pehlivanoglu, et al.
Pageof 65